ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca.
A recent report by the US Geological Survey (USGS) shows that much of Connecticut’s public groundwater supply areas, including areas that provide water to the state's largest cities, have a high ...